European Commission Broadens Trodelvy’s First-Line Use in Metastatic Triple-Negative Breast Cancer Regardless of PD-L1 Status Gilead Sciences, Inc.announced that the European Commission (EC) has granted marketing authorization for Trodelvy® (sacituzumab govitecan-hziy) in combination with Keytruda® (pembrolizumab) for the first-line treatment…
Genentech to Invest $750 Million in New Device Fill-Finish Manufacturing Facility in Oregon Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), has announced plans to invest approximately $750 million to establish a new device fill-finish manufacturing…
Regenerative Research Foundation Selected as a Winner of NIH’s Complement-ARIE Challenge The Regenerative Research Foundation has announced that its Neural Stem Cell Institute (NSCI) has been selected as a Phase 1 winner in the National Institutes of Health’s (NIH) Complement-ARIE…
Life Couriers Completes Acquisition by JLL Partners and Appoints Edward DeMartini as CEO to Drive Global Healthcare Logistics Growth Life Couriers, a global provider of time-critical healthcare logistics and transportation solutions, has completed its acquisition by JLL Partners, a New…
Natera Collaborates With Kupando Therapeutics to Monitor Molecular Response in Phase 1 Trial of Novel Immunotherapy KUP-101 Natera, Inc., a global leader in cell-free DNA analysis and precision medicine, has announced a new collaboration with Kupando Therapeutics to support a…
Integrated DNA Technologies Study Establishes New Benchmark for CRISPR Off-Target Detection and Analysis Integrated DNA Technologies (IDT), a Danaher company and a global provider of genomics solutions, has announced the publication of a new peer-reviewed study in Nature Communications that…
Bruker Expands Drug Discovery Capabilities with Majority Investment in MIMETAS and Organ-on-a-Chip Technology Bruker Corporation has announced a majority investment in MIMETAS B.V., a biotechnology company specializing in organ-on-a-chip platforms and advanced human tissue and disease models for pharmaceutical research…
AIDS Healthcare Foundation Supports Bipartisan SUSTAIN 340B Act to Strengthen and Protect Federal Drug Discount Program AIDS Healthcare Foundation (AHF) has welcomed the introduction of draft bipartisan legislation in the U.S. Senate aimed at addressing ongoing challenges facing the federal…
Expedition Therapeutics Raises Oversubscribed $115 Million Series B Financing and Advances EXPD-101 into Phase 2 Clinical Trial for COPD Expedition Therapeutics, a clinical-stage biotechnology company focused on developing innovative oral small-molecule therapies for inflammatory and respiratory diseases, has announced two…
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher to Accelerate Plozasiran Approval for Severe Hypertriglyceridemia Arrowhead Pharmaceuticals, Inc. has announced that it has entered into an agreement with an undisclosed third party to acquire a U.S. Food and Drug Administration (FDA)…
Family Heart Foundation Founder Katherine Wilemon Receives ASPC 2026 Honorary Fellow Award for Advancing Cardiovascular Disease Prevention The Family Heart Foundation, a leading nonprofit organization dedicated to research, education, advocacy, and patient support for inherited cardiovascular diseases, has announced that…
CareDx Reports Strong Second Quarter 2026 Results with 52% Revenue Growth and Raises Full-Year Financial Outlook CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company focused on transplant medicine, specialty oncology, and cell therapy, has announced strong financial results…